CLINICAL BIOCHEMISTRY, cilt.44, sa.5-6, ss.372-376, 2011 (SCI-Expanded)
Objectives: We investigated whether the human serum paraoxonase (PON1) Q/R 192 and M/L 55 polymorphisms are associated with the complications of the type 2 diabetes (T2D).